Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LIVN
LIVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LIVN News
LivaNova Options Trading Analysis
Feb 02 2026
NASDAQ.COM
Tesla, Microsoft, and Meta Earnings Capture Attention
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 28 2026
Yahoo Finance
Keybanc Begins Coverage of LivaNova (LIVN) with an Overweight Rating
Dec 20 2025
NASDAQ.COM
LivaNova Presents Significant Seizure Reduction with VNS Therapy at AES Annual Meeting
Dec 03 2025
Newsfilter
LivaNova Appoints New Global Head of Commercialization for OSA to Drive Market Growth
Dec 02 2025
Newsfilter
LivaNova's VNS Therapy Reimbursement Increases by 48% Under Medicare
Nov 24 2025
Newsfilter
LivaNova Unveils Strategic Plan and Long-Term Financial Outlook During Investor Day
Nov 12 2025
Newsfilter
Calculating the Components: IJH May Have a Value of $75
Oct 28 2025
NASDAQ.COM
Goldman Sachs Revises Ratings for Doximity and LivaNova in MedTech and Health IT Sector Review
Oct 01 2025
SeekingAlpha
Explore the Details: IVOO Shows Potential for 14% Growth
Sep 26 2025
NASDAQ.COM
LivaNova PLC (LIVN) Reaches 52-Week Peak: Is It Time to Sell?
Sep 08 2025
NASDAQ.COM
LivaNova Scheduled to Hold Investor Day on November 12, 2025
Aug 25 2025
Newsfilter
Barclays Keeps Equal-Weight Rating on LivaNova and Increases Price Target to $58
Aug 21 2025
Benzinga
Show More News
